Abacus Life Statistics
Total Valuation
Abacus Life has a market cap or net worth of $724.85 million. The enterprise value is $884.94 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Abacus Life has 93.89 million shares outstanding. The number of shares has increased by 23.61% in one year.
| Current Share Class | 93.89M |
| Shares Outstanding | 93.89M |
| Shares Change (YoY) | +23.61% |
| Shares Change (QoQ) | +11.21% |
| Owned by Insiders (%) | 67.14% |
| Owned by Institutions (%) | 14.13% |
| Float | 30.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 10.29 |
| PS Ratio | 4.99 |
| Forward PS | 4.37 |
| PB Ratio | 2.24 |
| P/TBV Ratio | 7.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.64 |
| EV / EBITDA | 31.73 |
| EV / EBIT | 42.15 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.29, with a Debt / Equity ratio of 0.71.
| Current Ratio | 1.29 |
| Quick Ratio | 1.20 |
| Debt / Equity | 0.71 |
| Debt / EBITDA | 6.33 |
| Debt / FCF | n/a |
| Interest Coverage | 1.12 |
Financial Efficiency
Return on equity (ROE) is -5.79% and return on invested capital (ROIC) is 3.62%.
| Return on Equity (ROE) | -5.79% |
| Return on Assets (ROA) | 3.36% |
| Return on Capital (ROIC) | 3.62% |
| Revenue Per Employee | $1.00M |
| Profits Per Employee | -$116,924 |
| Employee Count | 102 |
| Asset Turnover | 0.26 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Abacus Life has paid $1.91 million in taxes.
| Income Tax | 1.91M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.54% in the last 52 weeks. The beta is 0.12, so Abacus Life's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | -7.54% |
| 50-Day Moving Average | 8.50 |
| 200-Day Moving Average | 10.08 |
| Relative Strength Index (RSI) | 41.67 |
| Average Volume (20 Days) | 443,415 |
Short Selling Information
The latest short interest is 587,766, so 0.63% of the outstanding shares have been sold short.
| Short Interest | 587,766 |
| Short Previous Month | 741,401 |
| Short % of Shares Out | 0.63% |
| Short % of Float | 1.91% |
| Short Ratio (days to cover) | 2.36 |
Income Statement
In the last 12 months, Abacus Life had revenue of $102.41 million and -$11.93 million in losses. Loss per share was -$0.19.
| Revenue | 102.41M |
| Gross Profit | 93.09M |
| Operating Income | 21.00M |
| Pretax Income | 3.38M |
| Net Income | -11.93M |
| EBITDA | 27.89M |
| EBIT | 21.00M |
| Loss Per Share | -$0.19 |
Full Income StatementBalance Sheet
The company has $22.43 million in cash and $182.52 million in debt, giving a net cash position of -$160.09 million or -$1.71 per share.
| Cash & Cash Equivalents | 22.43M |
| Total Debt | 182.52M |
| Net Cash | -160.09M |
| Net Cash Per Share | -$1.71 |
| Equity (Book Value) | 257.94M |
| Book Value Per Share | 3.45 |
| Working Capital | 6.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$131.12 million and capital expenditures -$686,412, giving a free cash flow of -$131.80 million.
| Operating Cash Flow | -131.12M |
| Capital Expenditures | -686,412 |
| Free Cash Flow | -131.80M |
| FCF Per Share | -$1.40 |
Full Cash Flow StatementMargins
Gross margin is 90.90%, with operating and profit margins of 20.50% and -11.65%.
| Gross Margin | 90.90% |
| Operating Margin | 20.50% |
| Pretax Margin | -10.12% |
| Profit Margin | -11.65% |
| EBITDA Margin | 27.23% |
| EBIT Margin | 20.50% |
| FCF Margin | n/a |
Dividends & Yields
Abacus Life does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.61% |
| Shareholder Yield | -23.61% |
| Earnings Yield | -1.65% |
| FCF Yield | -18.18% |
Analyst Forecast
The average price target for Abacus Life is $14.38, which is 86.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.38 |
| Price Target Difference | 86.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 60.45% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Abacus Life has an Altman Z-Score of 2.07 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.07 |
| Piotroski F-Score | 2 |